AEGFX
Price
$56.46
Change
+$0.48 (+0.86%)
Updated
Jan 30 closing price
Net Assets
130B
CSIRX
Price
$27.63
Change
+$0.40 (+1.47%)
Updated
Jan 30 closing price
Net Assets
195.4M
Ad is loading...

AEGFX vs CSIRX

Header iconAEGFX vs CSIRX Comparison
Open Charts AEGFX vs CSIRXBanner chart's image
American Funds Europacific Growth F1
Price$56.46
Change+$0.48 (+0.86%)
VolumeN/A
Net Assets130B
Columbia Acorn International Sel Inst3
Price$27.63
Change+$0.40 (+1.47%)
VolumeN/A
Net Assets195.4M
AEGFX vs CSIRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEGFX vs. CSIRX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEGFX is a Hold and CSIRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
AEGFX has more cash in the bank: 130B vs. CSIRX (195M). AEGFX pays higher dividends than CSIRX: AEGFX (1.48) vs CSIRX (0.00). AEGFX was incepted earlier than CSIRX: AEGFX (24 years) vs CSIRX (12 years). CSIRX is a more actively managed with annual turnover of: 43.00 vs. AEGFX (34.00). AEGFX has a lower initial minimum investment than CSIRX: AEGFX (250) vs CSIRX (1000000). CSIRX annual gain was more profitable for investors over the last year : 9.78 vs. AEGFX (4.99). AEGFX return over 5 years is better than : 9.51 vs. CSIRX (-0.88).
AEGFXCSIRXAEGFX / CSIRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years12 years-
Gain YTD5.6125.98494%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets130B195M66,667%
Annual Yield % from dividends1.480.00-
Returns for 1 year4.999.7851%
Returns for 3 years-2.83-10.1828%
Returns for 5 years9.51-0.88-1,077%
Returns for 10 years23.8124.9395%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRI196.192.39
+1.23%
Darden Restaurants
MC77.770.41
+0.53%
Moelis & Company
NGNE15.530.02
+0.13%
Neurogene
NXTC0.80N/A
-0.03%
NextCure
QCRH78.13-0.25
-0.32%
QCR Holdings